CDW Holding (BXE) H1 2025 earnings summary

Executive summary

• H1 revenue was US$43.2m, down 1.3% YoY; the after-tax loss narrowed to US$1.0m from US$2.6m, supported by lower costs and stronger OEM performance.

• Market softness in backlight units and office automation was partly offset by OEM growth; management remains cautious on FY2025 amid economic and market uncertainty.

Financial highlights

• Revenue was US$43.199m versus US$43.749m; gross profit was US$6.932m versus US$7.583m, and gross margin was 16.0% versus 17.3%.

• Operating loss narrowed to US$0.338m from US$2.349m; loss before tax was US$0.502m versus US$2.498m, and net loss was US$0.953m versus US$2.562m.

• Administrative expenses fell 23.7% to US$7.003m; distribution costs declined 9.3% to US$0.946m, while other income rose to US$0.679m, including a US$0.506m FX gain.

• Basic and diluted loss per share improved to US$0.41 cent from US$1.03 cents; income tax expense rose to US$0.451m, mainly due to withholding taxes.

Outlook and guidance

• FY2025 outlook remains cautious amid economic conditions and market uncertainty, barring unforeseen circumstances.

• Backlight units strategy targets premium, high-functionality products, new vehicle-display technology and customer diversification; smaller units continue to face tapering demand.

• OEM order momentum supports evaluation of capacity expansion in Thailand and the Philippines; management is also pursuing new customer relationships.

• Office automation is targeting recovery through legacy-product transitions, selective automation, and new customers and product lines; further turnover declines could prompt segment consolidation into Others.

• Life-science projects remain early to mid-stage, with no near-term revenue expected; fundraising options include new investors and professional biotech funds.